Valentine Capital Asset Management’s Alaunos Therapeutics TCRT Stock Holding History

Valentine Capital Asset Management’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$50K	Buy	+41	New	+$67.8K	0.06%	84

Other funds holding TCRT

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Valentine Capital Asset Management's TCRT Position: Q4 2015 in Review

Valentine Capital Asset Management opened a new position in Alaunos Therapeutics (TCRT) in Q4 2015: 41 shares worth $50K. The stake represents 0.06% of the portfolio and ranks #84 among its holdings.

156 funds tracked by Wall St. Rank hold TCRT as of Q4 2015.

Valentine Capital Asset Management held 41 shares of Alaunos Therapeutics worth $50K as of Q4 2015.
Alaunos Therapeutics was a new Valentine Capital Asset Management position in Q4 2015.
Alaunos Therapeutics made up 0.06% of Valentine Capital Asset Management's portfolio in Q4 2015, its #84 holding.
156 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2015.

Based on Valentine Capital Asset Management's 13F filing for Q4 2015, filed 17 Feb 2016.